Balanced news tone
News Sentiment
ANIP sentiment intelligence
ANI Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-4.6% over one week, +0.5% over four weeks, trend active, and near fair-value range.
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?
- Tone
- Positive 58/100
- Event
- Earnings
- Published
- 10 Jun 2026 17:26
- Source
- Zacks
Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- Market source
Profitable Stocks: MYR Group & ANI Pharmaceuticals to Watch, B&G Foods to Sell - News and Statistics
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- IndexBox
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- The Motley Fool
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
ANI Pharmaceuticals (ANIP) Profit Swing And One Off Gain Test Bullish Narratives
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 09 May 2026 07:00
- Source
- simplywall.st
ANI Pharmaceuticals (ANIP) shares jump after earnings beat and higher outlook
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- Market source
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 May 2026 07:00
- Source
- GlobeNewswire
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Impressive Q1 CY2026, Stock Soars
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- StockStory
ANI Pharmaceuticals, Inc. (ANIP): A Small Cap Value Stock Capitalizing on Generic Drugs Opportunities
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- Market source
ANI Pharmaceuticals (ANIP) Q1 Earnings: What To Expect
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- StockStory
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- Market source
Is ANI Pharmaceuticals (ANIP) Pricing Reflect Its Strong Multi Year Share Price Performance?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 Apr 2026 07:00
- Source
- simplywall.st
ANI Pharmaceuticals News Highlights Undervalued Shares And New Specialty Generics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- simplywall.st
Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- TradingView
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- TradingView
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jan 2026 08:00
- Source
- Market source